Google Employees
Protest Working with Pentagon
to Make
Google Employees
Protest Working with Pentagon
to Make Drones More Accurate
< >
A letter signed by thousands of Google employees and addressed to Chief Executive Officer Sundar Pichai proclaims that Google should abstain from “the business of war.”
The letter, endorsed by over 3,100 employees of the tech giant, asks Google to cease all work on Project Maven, which is described as “a customized AI surveillance engine that uses ‘Wide Area Motion Imagery’ data captured by US Government drones to detect vehicles and other objects, track their motions, and provide results to the Department of Defense.”
The letter implores Google to do two things: First, to immediately cancel all involvement with Project Maven, and second, to “draft, publicize, and enforce a clear policy stating that neither Google nor its contractors will ever build warfare technology.” If not, the dissenting voices believe that “this plan will irreparably damage Google’s brand and its ability to compete for talent.”
The letter implores the company at large not to “outsource the moral responsibility of our technologies to third parties,” saying that “building this technology to assist the US Government in military surveillance — and potentially lethal outcomes — is not acceptable.”
advertisement
Ironically, Project Maven’s purpose is to reduce unnecessary civilian casualties, and both Google and the Pentagon itself have affirmed that the company will not be involved in the creation of any completely autonomous weapons systems. Google has characterized its work with the Pentagon as “non-offensive” in nature.
At a recent company-wide meeting, Google executive Diane Greene attempted to reassure employees and make a case for the project’s continuance. According to the company, the letter was circulated before the company had that chance to better explain the situation.
Later, Pichai himself released a statement addressing the project, though he neglected to mention the letter of protest directly. He said that while “any military use of machine learning naturally raises valid concerns,” Google remained “actively engaged across the company in a comprehensive discussion of this important topic.” Pichai also asserted that the internal dialogue was “hugely important and beneficial,” and, again, that their work was “specifically scoped to be for non-offensive purposes.”
Whether the response — as well as the stated goals of Project Maven itself — are disingenuous remains to be seen. At this point, it does not appear that the behemoth megacorporation is slowing its pace, regardless of employee reaction. Optimally, Google’s work with the project will provide a way to make aerial drone assaults much less lethal to any but those they are targeting.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...
Continue Reading
Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...
Continue Reading
Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...
Continue Reading
Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...
Continue Reading
Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...
Continue Reading
Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...
Continue Reading
A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...
Continue Reading
Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...
Continue Reading
Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...
Continue Reading
Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of the Human-Machine Interface Market The global human-machine interface (HMI) market is currently valued at about USD 4.07 billion and is expected to grow significantly, possibly reaching USD 10.64 billion within the next decade. This remarkable growth reflects a compound annual growth rate (CAGR) of 10.1%. The importance of Human-Machine Interfaces stems from...
Continue Reading
Leadership Transition at Mattel, Inc. Mattel, Inc. (NASDAQ: MAT), the recognized leader in toy production, has announced a significant transition within its executive team as its Chief Financial Officer, Anthony DiSilvestro, has plans to retire. The planned retirement is set for May, with the company actively searching for DiSilvestro's successor. The transition strategy...
Continue Reading
Groundbreaking Steps in Cancer Treatment with REC-3565 Recursion, a trailblazer in the TechBio realm, has announced an exciting new development: the first patient has been dosed in a Phase 1 clinical study of REC-3565, a selective MALT1 inhibitor aimed at treating relapsed or refractory B-cell lymphomas. This endeavor signifies a pivotal moment in the realm of...
Continue Reading
Legal Challenges Faced by Dow Inc. As one of the leading companies in materials science solutions, Dow Inc. (NYSE: DOW) is currently facing significant legal challenges that are affecting its investors. The ongoing situation involves a class action lawsuit aimed at protecting shareholders who bought Dow securities between late January and late July. The legal proceedings...
Continue Reading
Palvella Therapeutics Appoints New Chief Innovation Officer Palvella Therapeutics, Inc. has recently announced the appointment of Dr. David W. Osborne as their Chief Innovation Officer. With over 25 years of exceptional experience in the pharmaceutical industry, Dr. Osborne brings a wealth of knowledge in developing innovative therapies for serious, rare genetic skin...
Continue Reading